Combined Biodifferentiating and Antiangiogenic Oral Metronomic Therapy is Feasible and Effective in Relapsed Solid Tumors in Children: Single-Center Pilot Study

New Guidelines to Evaluate the Response to Treatment in Solid Tumors

2000 • 15,583 citations

Tumor Angiogenesis: Therapeutic Implications

1971 • 9,898 citations

Angiogenesis in cancer and other diseases

2000 • 8,734 citations

Transplacental Carcinogenesis by Stilbestrol

1971 • 2,595 citations

Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer

2004 • 2,481 citations

Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment.

1993 • 2,242 citations

Treatment of High-Risk Neuroblastoma with Intensive Chemotherapy, Radiotherapy, Autologous Bone Marrow Transplantation, and 13-cis-Retinoic Acid

1999 • 1,843 citations

Highly Efficacious Nontoxic Preclinical Treatment for Advanced Metastatic Breast Cancer Using Combination Oral UFT-Cyclophosphamide Metronomic Chemotherapy

2006 • 228 citations

A Feasibility Trial of Antiangiogenic (Metronomic) Chemotherapy in Pediatric Patients With Recurrent or Progressive Cancer

2005 • 194 citations

BMP-2 mediates retinoid-induced apoptosis in medulloblastoma cells through a paracrine effect

2003 • 185 citations

Phase I trial of 13-cis-retinoic acid in children with neuroblastoma following bone marrow transplantation.

1995 • 168 citations

Phase II Evaluation of Temozolomide and 13-cis-Retinoic Acid for the Treatment of Recurrent and Progressive Malignant Glioma: A North American Brain Tumor Consortium Study

2003 • 151 citations

Treatment of recurrent malignant gliomas with high-dose 13-cis-retinoic acid.

1996 • 121 citations

13‐cis‐retinoic acid (NSC 122758) in the treatment of children with metastatic neuroblastoma unresponsive to conventional chemotherapy: Report from the childrens cancer study group

1992 • 100 citations

Pioglitazone and rofecoxib combined with angiostatically scheduled trofosfamide in the treatment of far‐advanced melanoma and soft tissue sarcoma

2004 • 99 citations

All-trans-retinoic acid: a phase II Radiation Therapy Oncology Group study (RTOG 91-13) in patients with recurrent malignant astrocytoma.

1997 • 78 citations

Proangiogenic role of neutrophil-like inflammatory heterophils during neovascularization induced by growth factors and human tumor cells

2005 • 72 citations

Cancer Anti-angiogenic Therapy

2004 • 71 citations

The selective Cox-2 inhibitor Celecoxib suppresses angiogenesis and growth of secondary bone tumors: An intravital microscopy study in mice

2006 • 70 citations

All-trans retinoic acid in relapsing malignant gliomas: clinical and radiological stabilization associated with the appearance of intratumoral calcifications.

1997 • 58 citations

The treatment of recurrent cerebral gliomas with all-trans-retinoic acid (tretinoin).

1997 • 56 citations

Response and progression in recurrent malignant glioma

1999 • 53 citations

Pharmacokinetics of all-trans retinoic acid, 13-cis retinoic acid, and fenretinide in plasma and brain of Rat.

2000 • 52 citations

Regulation of the human tissue-nonspecific alkaline phosphatase gene expression by all-trans-retinoic acid in SaOS-2 osteosarcoma cell line

2005 • 51 citations

Disposition of all-trans- and 13-cis-retinoic acids and n-hydroxyethylretinamide in mice after intravenous administration.

1980 • 51 citations

A phase II study of concurrent temozolomide and cis-retinoic acid with radiation for adult patients with newly diagnosed supratentorial glioblastoma

2005 • 49 citations

Docetaxel and cyclooxygenase-2 inhibition with celecoxib for advanced non-small cell lung cancer progressing after platinum-based chemotherapy: a multicenter phase II trial

2005 • 49 citations

High cumulative rate of secondary leukemia after continuous etoposide treatment for solid tumors in children and young adults

2005 • 45 citations

Oral etoposide for recurrent/progressive sarcomas of childhood

2003 • 44 citations

Response and progression in recurrent malignant glioma

1999 • 39 citations

Treatment With Oral Etoposide for Childhood Recurrent Ependymomas

2005 • 39 citations

Fenretinide activates caspases and induces apoptosis in gliomas.

1999 • 39 citations

Differentiation of rhabdomyosarcoma cell lines using retinoic acid

2005 • 38 citations

High-Dose Chemotherapy in Childhood Brain Tumors

2004 • 28 citations

Inhibition of epidermal growth factor receptor activity by retinoic acid in glioma cells

1990 • 28 citations

Dimethyl celecoxib as a novel non–cyclooxygenase 2 therapy in the treatment of non–small cell lung cancer

2005 • 26 citations

All-trans retinoic acid and interferon-α in the treatment of a patient with resistant metastatic osteosarcoma

2000 • 24 citations

Antineovascular therapy, a novel antiangiogenic approach

2005 • 21 citations

Effects of all-trans retinoic acid on tumor recurrence and metastasis

2005 • 15 citations

Low-Dose Thalidomide for Multiple Myeloma: Interim Analysis of a Compassionate Use Program

2004 • 12 citations

Merkel Cell Carcinoma – a Rarity in the Urogenital Tract

2006 • 10 citations

EXPRESSION AND REGULATION OF THE TRANSCRIPTIONAL REPRESSOR ZNF43 IN EWING SARCOMA CELLS

2002 • 9 citations

No responses to oral etoposide in 15 patients with recurrent brain tumors

2000 • 9 citations

Contemporary therapeutic options for children with high risk neuroblastoma.

2002 • 8 citations

Relapse after High-Dose Therapy in Relapsed Ewing’s Tumor Patients: Effects of Maintenance Chemotherapy in Two Selected Patients?

2003 • 4 citations